Cite
HARVARD Citation
Nakamura, M. et al. (n.d.). 440PA multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting (ESPRESSO-02/HGCSG1602). Annals of oncology. p. . [Online].